Gabbroral

Gabbroral: an antibiotic from Italy

Gabbroral is an antibiotic produced in Italy by the company Carlo Erba Farmitalia. It belongs to the group of aminoglycosides and is widely used to treat infections caused by gram-negative bacteria.

The international name of this drug is Paromomycin. It is available in two dosage forms: 250 mg tablets and 1.5 g syrup. Gabbroral is widely used in the treatment of infections of the urinary tract, lungs, abdominal cavity, as well as bacterial infections of the skin and soft tissues.

Since Gabbroral belongs to the group of aminoglycosides, it acts by inhibiting protein synthesis in bacteria, which leads to their death. Treatment with Gabbroral should only be carried out under the supervision of a physician, as the drug can cause serious side effects such as hearing and kidney damage.

Despite the side effects, Gabbroral is one of the most effective antibiotics for treating many types of infections. Patients should follow their doctor's instructions and not stop taking the drug without their permission.

Thus, Gabbroral is a powerful antibiotic that can be effective in treating many infections. But, like any other medication, its use must be justified and carried out only under the supervision of a doctor.